14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $116.30 $116.30 Thursday, 4th Jan 2024 HZNP stock ended at $116.30. During the day the stock fluctuated 0% from a day low at $116.30 to a day high of $116.30.
90 days $116.30 $116.30
52 weeks $90.61 $116.38

Historical Horizon Therapeutics Public Limited Company prices

Date Open High Low Close Volume
Aug 11, 2023 $104.40 $104.58 $104.00 $104.26 889 194
Aug 10, 2023 $104.45 $104.95 $103.62 $104.65 1 413 312
Aug 09, 2023 $103.61 $104.70 $103.61 $104.65 1 398 408
Aug 08, 2023 $102.62 $104.29 $102.24 $104.08 3 691 455
Aug 07, 2023 $100.82 $101.29 $100.05 $101.14 1 809 771
Aug 04, 2023 $99.71 $100.50 $99.68 $100.13 1 472 818
Aug 03, 2023 $98.82 $99.41 $98.80 $98.98 1 096 052
Aug 02, 2023 $99.50 $99.99 $98.96 $99.01 1 096 481
Aug 01, 2023 $100.17 $100.50 $99.27 $99.69 1 293 005
Jul 31, 2023 $99.80 $100.33 $99.70 $100.27 887 971
Jul 28, 2023 $99.65 $100.34 $99.52 $99.94 783 839
Jul 27, 2023 $99.95 $100.06 $99.48 $99.60 918 360
Jul 26, 2023 $100.00 $100.26 $99.67 $99.92 1 828 906
Jul 25, 2023 $100.22 $100.69 $99.88 $100.23 2 278 052
Jul 24, 2023 $100.27 $101.27 $99.98 $100.40 2 142 877
Jul 21, 2023 $101.85 $102.17 $100.72 $101.18 3 526 596
Jul 20, 2023 $103.85 $103.97 $100.92 $101.98 5 317 814
Jul 19, 2023 $104.25 $104.33 $103.70 $104.03 951 191
Jul 18, 2023 $104.29 $104.30 $103.95 $104.00 733 625
Jul 17, 2023 $104.20 $104.52 $103.86 $104.00 1 199 673
Jul 14, 2023 $103.90 $104.05 $103.76 $103.94 918 467
Jul 13, 2023 $103.50 $103.75 $103.23 $103.70 732 636
Jul 12, 2023 $102.96 $103.90 $102.72 $103.50 1 124 461
Jul 11, 2023 $102.50 $103.68 $102.11 $103.00 2 741 007
Jul 10, 2023 $102.58 $102.99 $102.56 $102.63 860 133
Click to get the best stock tips daily for free!

About Horizon Therapeutics Public Limited Company

Horizon Therapeutics Public Limited Company Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines in the areas of rare diseases, gout, ophthalmology, and inflammation. It markets TEPEZZA (teprotumumab-... HZNP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT